For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Shire Viropharma Incorporated

USPTO Granted Patents = 11

CIPO Patents = 8

EPO Patents = 8

Trademarks = 3

Forward Citations = 28

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Stephen Ruddy (5 out of 7 patents)

Mark Cornell Manning (5 out of 84 patents)

Ryan Erik Holcomb (5 out of 15 patents)

4. Colin Broom (3 out of 4 patents)

5. Jeffrey Dayno (2 out of 3 patents)

6. John D Peabody, Iii (2 out of 5 patents)

7. Marc E Uknis (1 out of 7 patents)

8. Jörgen Johnsson (1 out of 4 patents)

9. Hans Lennernäs (1 out of 12 patents)

10. Thomas Hedner (1 out of 11 patents)

11. Gudmundur Johannsson (1 out of 4 patents)

12. Stanko Skrtic (1 out of 6 patents)

13. Cynthia Gallagher (0 patent)

14. Ulrika Sigrida Helena Simonsson (0 patent)

11 patents: Sort by Forward Citations

1. 10786557 - Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders (2020-09-29),

2. 10765692 - Maribavir isomers, compositions, methods of making and methods of using (2020-09-08),

3. 10583146 - Pharmaceutical compositions for glucocorticoid replacement therapy (2020-03-10),

4. 10485813 - Maribavir isomers, compositions, methods of making and methods of using (2019-11-26),

5. 10272142 - Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders (2019-04-30),

6. 10201595 - C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency (2019-02-12),

7. 10130690 - C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency (2018-11-20),

8. 10105423 - C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency (2018-10-23),

9. 10080788 - C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency (2018-09-25),

10. 9895428 - Methods of treating antibody-mediated rejection in organ transplant patients with C1-esterase inhibitor (2018-02-20),

11. 9616111 - C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency (2017-04-11),

Shire Viropharma Incorporated is a biopharmaceutical company specializing in the development and commercialization of innovative treatments for serious diseases. With a focus on rare genetic disorders and diseases, the company aims to improve patients' lives by delivering life-changing therapies. Shire Viropharma is dedicated to advancing scientific research and discovering breakthrough solutions to improve healthcare outcomes globally.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

11 Patents

#65 in Lexington, MA

#1,611 in Massachusetts

#26,680 in US

#50,159 in the World

Lexington, MA, United States of America

Shire Viropharma Incorporated

Forward Citations = 28

29 inventors:

Stephen Ruddy (5 out of 7 patents)

Mark Cornell Manning (5 out of 84 patents)

Ryan Erik Holcomb (5 out of 15 patents)

4. Colin Broom (3 out of 4 patents)

5. Jeffrey Dayno (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…